Stockreport

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas [Yahoo! Finance]

MAIA Biotechnology, Inc.  (MAIA) 
PDF clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the FDA has designated THIO for the treatment of pediatric- [Read more]